These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2720692)

  • 21. [Intraperitoneal versus intravenous infusion of cis-platinum in advanced ovarian cancer--examination of pharmacokinetics].
    Shindo K; Oikawa N; Atsumi Y; Chida S; Tuburaya T; Yajima A
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):639-44. PubMed ID: 3827260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the intraperitoneal and intravenous routes of cisplatin administration in an advanced ovarian cancer model of the rat.
    Sekiya S; Iwasawa H; Takamizawa H
    Am J Obstet Gynecol; 1985 Sep; 153(1):106-11. PubMed ID: 4041136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis.
    Hribaschek A; Meyer F; Schneider-Stock R; Pross M; Ridwelski K; Lippert H
    Chemotherapy; 2007; 53(6):410-7. PubMed ID: 17952000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
    Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Hamburger DR; Delauter BJ; Grim A; Zuhowski EG; Joseph E; Pluim D; Potter DM; Eiseman JL
    Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trials with intraperitoneal cisplatin microspheres for malignant ascites--a pilot study.
    Hagiwara A; Takahashi T; Sawai K; Sakakura C; Tsujimoto H; Osaki K; Sakakibara T; Ohyama T; Ohgaki M; Muranishi S
    Anticancer Drug Des; 1993 Dec; 8(6):463-70. PubMed ID: 8286013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC).
    Zeamari S; Floot B; van der Vange N; Stewart FA
    Anticancer Res; 2003; 23(2B):1643-8. PubMed ID: 12820435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental study on intraperitoneal sequential MTX/5-FU therapy for peritoneal seeding in comparison with intravenous administration].
    Maruyama M; Takamatsu S; Sugano N; Ebuchi M; Endo M; Yuasa Y
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2131-6. PubMed ID: 9388524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers].
    Kurihara N; Kumai K; Kubota T; Furukawa T; Yamamoto T; Shimada A; Shibata S; Saikawa Y; Ogawa S; Murayama Y
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1645-8. PubMed ID: 8373238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound triggered release of cisplatin from liposomes in murine tumors.
    Schroeder A; Honen R; Turjeman K; Gabizon A; Kost J; Barenholz Y
    J Control Release; 2009 Jul; 137(1):63-8. PubMed ID: 19303426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ["Two route chemotherapy" of intra-arterial cis-diamminedichloroplatinum(II) and intravenous administration of its antidote, sodium thiosulfate, for rat bladder tumor].
    Sagiyama K
    Fukuoka Igaku Zasshi; 1983 Feb; 74(2):101-10. PubMed ID: 6682826
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions.
    Mohamed F; Marchettini P; Stuart OA; Sugarbaker PH
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):405-10. PubMed ID: 12879282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin--a Sankai Gynecology Study Group (SGSG) study.
    Miyagi Y; Fujiwara K; Kigawa J; Itamochi H; Nagao S; Aotani E; Terakawa N; Kohno I;
    Gynecol Oncol; 2005 Dec; 99(3):591-6. PubMed ID: 16095677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intraperitoneal cisplatin plus epinephrine and surgical debulking for the treatment of advanced peritoneal carcinomatosis in the rat].
    Benoit L; Duvillard C; Beltramo JL; Brunet-Lecomte P; Chauffert B
    Gastroenterol Clin Biol; 2000 Jan; 24(1):26-30. PubMed ID: 10679584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracavitary therapy of murine ovarian cancer with cis-diamminedichloroplatinum(II) and 10-ethyl-10-deazaaminopterin incorporating systemic leucovorin protection.
    Sirotnak FM; Schmid FA; DeGraw JI
    Cancer Res; 1989 Jun; 49(11):2890-3. PubMed ID: 2785847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the iv and ip routes of administration of cisplatin in dogs.
    Pretorius RG; Petrilli ES; Kean CK; Ford LC; Hoeschele JD; Lagasse LD
    Cancer Treat Rep; 1981; 65(11-12):1055-62. PubMed ID: 7197584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of two-route chemotherapy using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II in a rat limb tumor.
    Kuroiwa T; Aoki K; Taniguchi S; Hasuda K; Baba T
    Cancer Res; 1987 Jul; 47(14):3618-23. PubMed ID: 3594429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma and tumor concentrations of cisplatin following intraperitoneal infusion or bolus injection with or without continuous low-dose-rate irradiation.
    Fu KK; DeGregorio MW; Phillips JW
    NCI Monogr; 1988; (6):123-7. PubMed ID: 3281027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cisplatin/5-fluorouracil intraperitoneal administration superior to intravenous administration for liver metastases of colonic carcinoma].
    Maruyama M; Kudo T; Kuwahara H; Takamatsu S; Sugano N; Ebuchi M
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):2011-4. PubMed ID: 9350251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetics study of intraperitoneal cisplatin in ovarian carcinoma].
    Han GR; Cai GF
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):224-6, 254. PubMed ID: 8404307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.